gms | German Medical Science

128. Kongress der Deutschen Gesellschaft für Chirurgie

Deutsche Gesellschaft für Chirurgie

03.05. - 06.05.2011, München

Sitzungen am 04.05.2011
Onkologie: Prognose

Meeting Abstract (11dgch341)

Association between tumour recurrence and genetic instability in soft tissue sarcoma

Krieg A, Will D, Topp S, Stoecklein N, Reinecke P, Driemel C, Knoefel W
Meeting Abstract (11dgch342)

Neural invasion is not a prognostic factor in colon cancer due to missing neuro-cancer cell affinity

Liebl F, Demir IE, Rosenberg R, Kehl T, Boldis A, Becker K, Maak M, Friess H, Ceyhan GO
Meeting Abstract (11dgch343)

Specific activity of cyclin dependent kinase 1 as a novel predictor of recurrence risk in stage II colon cancer

Maak M, Zeestraten E, Shibayama M, Schuster T, Matsushima T, Nakayama S, Friess H, Van De Velde CJH, Ishihara H, Rosenberg R, Kuppen PJK, Janssen KP
Meeting Abstract (11dgch344)

Invasion front-specific overexpression of ZEB2 is an independent prognostic marker in colorectal cancer and regulates tumor invasion in vitro

Kahlert C
Meeting Abstract (11dgch345)

CpG island methylator phenotype infers a poor prognosis in locally advanced rectal cancer

Jo P, Jung K, Grade M, Conradi LC, Wolff HA, Becker H, Rüschoff J, Hartmann A, Beissbarth T, Müller-Dornieden A, Ghadimi M, Schneider-Stock R, Gaedcke J
Meeting Abstract (11dgch346)

EGF +61 A>G polymorphism predicts complete pathologic response independent of KRAS status in locally advanced rectal cancer patients undergoing neoadjuvant cetuximab-based chemoradiation

Vallböhmer D, Hu-Lieskovan S, Grimminger P, Brabender J, Hölscher AH, Semrau R, Arnold D, Machiels JP, Rödel C, Velenik V, Lenz HJ
Meeting Abstract (11dgch347)

Prognostic Biomarker in rectal cancer patients: Thymidylate Synthase for risk stratification after 5-FU-based neoadjuvant radiochemotherapy

Conradi LC, Bleckmann A, Schirmer M, Sprenger T, Jo P, Homayounfar K, Wolff HA, Rothe H, Becker H, Ghadimi M, Beissbarth T, Liersch T